This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Work, L. M. Articles by Wainwright, C. L. Search for Related Content PubMed PubMed Citation Articles by Work, L. M. Articles by Wainwright, C. L. Related Collections Restenosis Animal models of human disease Smooth muscle proliferation and differentiation Catheter-based coronary and valvular interventions: other

(Circulation. 2001;104:1538.)
© 2001 American Heart Association, Inc.

Basic Science Reports

Short-Term Local Delivery of an Inhibitor of Ras Farnesyltransferase Prevents Neointima Formation In Vivo After Porcine Coronary Balloon Angioplasty

Lorraine M. Work, BSc, PhD; Allan R. McPhaden, BSc, MBChB, MD, MRCPath; Nigel J. Pyne, BSc, PhD; Susan Pyne, BSc, PhD; Roger M. Wadsworth, BPharm, PhD, DSc; Cherry L. Wainwright, BSc, PhD, FESC

From the Department of Physiology and Pharmacology, University of Strathclyde, and Department of Pathology, Glasgow Royal Infirmary (A.R.M.), Glasgow, Scotland, UK. Dr Work is now at the Department of Medicine and Therapeutics, Western Infirmary, Glasgow.

Correspondence to Dr C.L. Wainwright, Department of Physiology and Pharmacology, University of Strathclyde, Strathclyde Institute for Biomedical Sciences, 27 Taylor St, Glasgow G4 0NR, Scotland, UK. E-mail c.l.wainwright{at}strath.ac.uk

Background— Mitogenic stimuli present at the site of coronary arterial balloon injury contribute to the progression and development of a restenotic lesion, many signaling through a common pathway involving the small G protein p21^ras. Our aim was to demonstrate in biochemical studies that farnesyl protein transferase inhibitor III (FPTIII) is an inhibitor of p21^ras processing and that when it is given locally in vivo at the site of coronary balloon injury in a porcine model, it can inhibit neointima formation.

Methods and Results— FPTIII (1 to 25 µmol/L) concentration-dependently reduced p21^ras levels in porcine coronary artery smooth muscle cell membranes. FPTIII also prevented p42/p44 MAPK activation and DNA synthesis in response to platelet-derived growth factor in these cells at a concentration of 25 µmol/L. Application of 25 µmol/L FPTIII locally for 15 minutes to balloon-injured porcine coronary arteries in vivo prevented neointima formation assessed at 4 weeks, reduced proteoglycan deposition, and inhibited adventitial hypertrophy. Coronary arteries from FPTIII-treated pigs had no deterioration in contraction or in endothelium-dependent relaxation.

Conclusions— The study demonstrates in the pig that short-term local delivery of inhibitors of p21^ras-dependent mitogenic signal transduction prevents restenosis after balloon angioplasty.

Key Words: neointima • farnesyl transferase inhibitor • arteries • angioplasty

This article has been cited by other articles:

				K. S. Ramos H-RAS Controls Phenotypic Profiles of Vascular Smooth Muscle Cells and the Pathogenesis of Vascular Proliferative Disorders Circ. Res., May 22, 2009; 104(10): 1139 - 1141. [Full Text] [PDF]

				D. G. Sedding, M. Trobs, F. Reich, G. Walker, L. Fink, W. Haberbosch, W. Rau, H. Tillmanns, K. T. Preissner, R. M. Bohle, et al. 3-Deazaadenosine Prevents Smooth Muscle Cell Proliferation and Neointima Formation by Interfering With Ras Signaling Circ. Res., May 22, 2009; 104(10): 1192 - 1200. [Abstract] [Full Text] [PDF]

				L. Chang, J. Zhang, Y.-H. Tseng, C.-Q. Xie, J. Ilany, J. C. Bruning, Z. Sun, X. Zhu, T. Cui, K. A. Youker, et al. Rad GTPase Deficiency Leads to Cardiac Hypertrophy Circulation, December 18, 2007; 116(25): 2976 - 2983. [Abstract] [Full Text] [PDF]

				M. Huang, J. B. DuHadaway, G. C. Prendergast, and L. D. Laury-Kleintop RhoB Regulates PDGFR- Trafficking and Signaling in Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2597 - 2605. [Abstract] [Full Text] [PDF]

				X. Guo, K.-H. Chen, Y. Guo, H. Liao, J. Tang, and R.-P. Xiao Mitofusin 2 Triggers Vascular Smooth Muscle Cell Apoptosis via Mitochondrial Death Pathway Circ. Res., November 26, 2007; 101(11): 1113 - 1122. [Abstract] [Full Text] [PDF]

				F. Li, A. M. Munchhof, H. A. White, L. E. Mead, T. R. Krier, A. Fenoglio, S. Chen, X. Wu, S. Cai, F.-C. Yang, et al. Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells Hum. Mol. Genet., June 1, 2006; 15(11): 1921 - 1930. [Abstract] [Full Text] [PDF]

				B. Jaschke, C. Michaelis, S. Milz, M. Vogeser, T. Mund, L. Hengst, A. Kastrati, A. Schomig, and R. Wessely Local statin therapy differentially interferes with smooth muscle and endothelial cell proliferation and reduces neointima on a drug-eluting stent platform Cardiovasc Res, December 1, 2005; 68(3): 483 - 492. [Abstract] [Full Text] [PDF]

				C. D. Meyers, L. R. Tannock, T. N. Wight, and A. Chait Statin-exposed vascular smooth muscle cells secrete proteoglycans with decreased binding affinity for LDL J. Lipid Res., November 1, 2003; 44(11): 2152 - 2160. [Abstract] [Full Text] [PDF]

				A. M. Taylor and C. A. McNamara Regulation of Vascular Smooth Muscle Cell Growth: Targeting the Final Common Pathway Arterioscler. Thromb. Vasc. Biol., October 1, 2003; 23(10): 1717 - 1720. [Full Text] [PDF]

				S. Zhang, J. Ren, M. F. Khan, A. M. Cheng, D. Abendschein, and A. J. Muslin Grb2 Is Required for the Development of Neointima in Response to Vascular Injury Arterioscler. Thromb. Vasc. Biol., October 1, 2003; 23(10): 1788 - 1793. [Abstract] [Full Text] [PDF]

				C. Barandier, X.-F. Ming, and Z. Yang Small G Proteins as Novel Therapeutic Targets in Cardiovascular Medicine Physiology, February 1, 2003; 18(1): 18 - 22. [Abstract] [Full Text] [PDF]